MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search
  • 2017 International Congress

    The Role of Social Work in Improving Comprehensive Care for Parkinson’s Disease

    E. Book, A. Lemen (Vancouver, BC, Canada)

    Objective: The poster will create awareness as well as describe the role and the value of social work in improving comprehensive Parkinson’s care for patients…
  • 2017 International Congress

    Study of an early wellness program in Parkinson’s disease: impact on quality of life and early intervention guidance

    B. Page, H. Shill (Phoenix, AZ, USA)

    Objective: This study examined whether intervening early in PD with a comprehensive Wellness Program is feasible and promotes lasting habits that will continue to provide…
  • 2017 International Congress

    Physical Activity and Quality of Life in People with Parkinson’s Disease – A Long-term Follow-up Study

    I-F. Shih, K. Paul, J. Bronstein, B. Ritz (Los Angeles, CA, USA)

    Objective: This study aims to examine associations between changes in physical activity (PA) and health-related quality of life (HRQOL) among Parkinson disease (PD) patients. Background:…
  • 2017 International Congress

    Two patients with dystonia treated with internal globus pallidus deep brain stimulation (GPi-DBS) using a multiple independent source current-controlled system,long term results,a case report


    O. Morsi, J. Jimenez, J. Lopez, B. Cuartero, J. Zamarro, R. Sanchez, M. Felipe, J.J. Martin (Murcia, Spain)

    Objective: To assess long term benefit of multiple source current steering in two dystonic patients with GPi-DBS. Background: GPi-DBS proved to be safe and effective…
  • 2017 International Congress

    Evaluating Use of the DBS Patient Programmer

    D. Whitney, J. Karl, G. Pal, D. Ocegueda-Ramirez, B. Ouyang, L. Verhagen Metman (Chicago, IL, USA)

    Objective: To characterize use of the Medtronic® DBS patient programmer among patients with DBS for movement disorders. Background: Patients who undergo deep brain stimulation receive…
  • 2017 International Congress

    Spinal cord stimulation reduces freezing of gait and improves gait in advanced Parkinson’s disease

    O. Samotus, N. Kumar, S. Memar, M. Jog (London, ON, Canada)

    Objective: The primary objective was to investigate the therapeutic effect of spinal cord stimulation (SCS) on gait dysfunction including freezing of gait (FOG) in advanced…
  • 2017 International Congress

    The DBS response ratio: An individual benchmark parameter of DBS quality

    L. Lange, M. Reich, R. Nickl, F. Steigerwald, C. Matthies, J. Volkmann (Wuerzburg, Germany)

    Objective: The aim of this study is to define a simple clinical benchmark parameter for assessing the quality of STN-DBS outcome in PD. Background: Despite…
  • 2017 International Congress

    The battery longevity of implantable pulse generators (IPG) in Parkinson’s disease (PD) is affected by IPG model, number of previous IPG replacements and stimulation energy delivered.

    S. Israeli-Korn, T. Fay-Karmon, S. Tessler, G. Yahalom, S. Benizri, H. Strauss, Z. Zibly, R. Spiegelmann, S. Hassin (Ramat Gan, Israel)

    Objective: To determine the effects of stimulation parameters, IPG model and the number of previous IPG replacements on IPG battery longevity. Background: For some patients rechargeable…
  • 2017 International Congress

    Asymptomatic and transitory postoperative hypodense lesion around deep brain stimulation electrode

    M. Sousa, F. Moreira, N. Canário, O. Brito, R. Pereira, M. Rito, C. Januário (Coimbra, Portugal)

    Objective: To report the case of a patient that developed a post-operative asymptomatic, transitory, non-infection hypodense lesion around DBS lead, literature review and discussion of…
  • 2017 International Congress

    Addressing Involuntary Movements in Tardive Dyskinesia (AIM-TD): Improvements in Clinical Global Impression of Change (CGIC) with Deutetrabenazine Treatment in Tardive Dyskinesia (TD)

    J. Jimenez-Shahed, H. Fernandez, R. Hauser, M. Davis, S. Factor, J. Isojärvi, W. Ondo, D. Stamler, K. Anderson (Houston, TX, USA)

    Objective: To determine the efficacy of deutetrabenazine in patients with TD as measured by CGIC. Background: TD is often irreversible and can affect any body…
  • « Previous Page
  • 1
  • …
  • 107
  • 108
  • 109
  • 110
  • 111
  • …
  • 155
  • Next Page »

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • #23285 (not found)
  • The hardest symptoms that bother patients with Parkinson's disease
  • Life expectancy with and without Parkinson’s disease in the general population
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Estimation of the 2020 Global Population of Parkinson’s Disease (PD)
  • Patients with Essential Tremor Live Longer than their Relatives
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley